Amphastar Pharmaceuticals (AMPH) EPS (Diluted) Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) EPS (Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 6.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.43% |
| Mar 31, 2026 | -72.73% |
| Dec 31, 2025 | 35.33% |
| Sep 30, 2025 | -53.32% |
| Jun 30, 2025 | -11.58% |
| Mar 31, 2025 | -38.59% |
| Dec 31, 2024 | 126.61% |
| Sep 30, 2024 | -15.27% |
| Jun 30, 2024 | 46.52% |
| Mar 31, 2024 | 59.93% |
| Dec 31, 2023 | -522.95% |
| Sep 30, 2023 | 202.86% |
| Jun 30, 2023 | 50.50% |
| Mar 31, 2023 | 7.48% |
| Dec 31, 2022 | 61.55% |
| Sep 30, 2022 | -50.93% |
| Jun 30, 2022 | 90.04% |
| Mar 31, 2022 | 500.52% |
| Dec 31, 2021 | 440.18% |
| Sep 30, 2021 | 543.86% |